Bedirli Nurdan, Akçabay Mehmet, Emik Ulku
Department of Anesthesiology, Gazi University Medical School, Kumeevler cad., Siyasal sit., No:44, 06810, Cayyolu, Ankara, Turkey.
BMC Anesthesiol. 2017 Mar 11;17(1):41. doi: 10.1186/s12871-017-0332-4.
This study was designed to compare the efficacy of an intraoperative single dose administration of tramadol and dexmedetomidine on hemodynamics and postoperative recovery profile including pain, sedation, emerge reactions in pediatric patients undergoing adenotonsillectomy with sevoflurane anesthesia.
Seventy-seven patient, aged 2-12, undergoing adenotonsillectomy with sevoflurane anesthesia was enrolled in this study. Patients were randomly assigned to receive either intravenous 2 mg/kg tramadol (Group T; n = 39) or 1 μg/kg dexmedetomidine (Group D; n = 38) after intubation. Heart rates (HR), mean arterial pressure (MAP) were recorded before induction, at induction and every 5 min after induction. Observational pain scores (OPS), pediatric anesthesia emergence delirium (PAED) scores, percentage of patients with OPS ≥ 4 or PAED scale items 4 or 5 with an intensity of 3 or 4, and Ramsay sedation scores (RSS) were recorded on arrival to the postoperative care unit (PACU) and at 5, 10, 15, 30, 45, 60 min. Extubation time and time to reach Alderete score > 9 were recorded.
Dexmedetomidine significantly decreased the HR and MAP 10 and 15 min after induction; increased the RSS 15, 30 and 45 min after arrival to PACU. OPS and PAED scores and percentage of patients with OPS ≥ 4 or PAED scale items 4 or 5 with an intensity of 3 or 4 in both groups did not show any significant difference. Extubation time and time to have Alderete score > 9 was significantly longer in Group D.
Both tramadol and dexmedetomidine were effective for controlling pain and emergence agitation. When compared with tramadol intraoperative hypotension, bradycardia and prolonged sedation were problems related with dexmedetomidine administration.
Retrospectively registered, registration number: ISRCTN89326952 registration date: 14.07.2016.
本研究旨在比较术中单次给予曲马多和右美托咪定对接受七氟醚麻醉的小儿腺样体扁桃体切除术患者血流动力学及术后恢复情况(包括疼痛、镇静、苏醒反应)的影响。
本研究纳入77例年龄在2至12岁、接受七氟醚麻醉的腺样体扁桃体切除术患者。患者在插管后随机分为两组,分别静脉注射2mg/kg曲马多(T组;n = 39)或1μg/kg右美托咪定(D组;n = 38)。记录诱导前、诱导时及诱导后每隔5分钟时的心率(HR)、平均动脉压(MAP)。在患者到达术后监护病房(PACU)时以及5、10、15、30、45、60分钟时记录观察性疼痛评分(OPS)、小儿麻醉苏醒期谵妄(PAED)评分、OPS≥4或PAED量表项目4或5且强度为3或4的患者百分比以及Ramsay镇静评分(RSS)。记录拔管时间及达到Aldrete评分>9的时间。
右美托咪定在诱导后10分钟和15分钟时显著降低HR和MAP;在到达PACU后15、30和45分钟时提高RSS。两组的OPS和PAED评分以及OPS≥4或PAED量表项目4或5且强度为3或4的患者百分比均无显著差异。D组的拔管时间及达到Aldrete评分>9的时间显著更长。
曲马多和右美托咪定均能有效控制疼痛和苏醒期躁动。与曲马多相比,右美托咪定术中低血压、心动过缓和镇静时间延长是与之相关的问题。
回顾性注册,注册号:ISRCTN89326952,注册日期:2016年7月14日。